CD8A and neoplasm: The feasibility of using two 64Cu-labeled engineered minibodies, 64Cu-NOTA-2.43 and 64Cu-NOTA-YTS169, for monitoring CD8+ T cells has been confirmed in non-tumor murine models (68).